Information  X 
Enter a valid email address

Dechra Pharma PLC Ord 1P (DPH)

Related News

21-Feb-2022 09:11 AM

TOP NEWS: Dechra Pharmaceuticals profit grows on more spending on pets

(Alliance News) - Dechra Pharmaceuticals PLC on Monday reported higher half-year profit and revenue amid increased consumer spending on pets. For the six months that ended December 31, Dechra posted pretax profit of GBP53.4 million, up 5
27-Oct-2020 07:59 AM

Dechra Pharmaceuticals sees better-than-expected performance in first quarter

Veterinary pharmaceutical company Dechra Pharmaceuticals said trading in the first quarter of the financial year had been stronger than expected, though continued to tout uncertainty on the outlook for the year. '[A]t this early stage of the year th
07-Sep-2020 07:59 AM

Dechra lifts dividend as profit raises on higher revenue in European pharmaceuticals business

Veterinary pharmaceutical business Dechra raised its dividend after reporting a jump in profit, driven by performance in its European pharmaceuticals business. For the year ended 30 June 2020, pre-tax profit rose by 47% to £40.9m on-year as reven
24-Aug-2020 08:30 AM

Broker Forecast - Liberum Capital issues a broker note on Dechra Pharmaceuticals PLC

Liberum Capital today initiates coverage of Dechra Pharmaceuticals PLC (LON:DPH) with a sell investment rating and price target of 2740p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
22-Jul-2020 10:50 AM

Broker Forecast - Jefferies International issues a broker note on Dechra Pharmaceuticals PLC

Jefferies International today reaffirms its buy investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and raised its price target to 3515p (from 3185p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk
09-Jul-2020 07:17 AM

Dechra Pharmaceuticals revenue rises, led by performance of core portfolio

Pharmaceuticals company Dechra Pharmaceuticals reported a rise in revenue led by 'good' market penetration of its core portfolio. For the financial year ended 30 June 2020, revenue increased by about 7% at constant and actual exchange rates.
05-Jun-2020 11:10 AM

Broker Forecast - JP Morgan Cazenove issues a broker note on Dechra Pharmaceuticals PLC

JP Morgan Cazenove today reaffirms its overweight investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and cut its price target to 3200p (from 3300p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk.
04-Jun-2020 01:30 PM

Broker Forecast - RBC Capital Markets issues a broker note on Dechra Pharmaceuticals PLC

RBC Capital Markets today reaffirms its sector performer investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and cut its price target to 2510p (from 2560p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine
24-Apr-2020 01:50 PM

Broker Forecast - HSBC issues a broker note on Dechra Pharmaceuticals PLC

HSBC today reaffirms its hold investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and raised its price target to 3085p (from 3020p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
13-Mar-2020 12:20 PM

Broker Forecast - RBC Capital Markets issues a broker note on Dechra Pharmaceuticals PLC

RBC Capital Markets today reaffirms its sector performer investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and raised its price target to 2530p (from 2500p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagaz
25-Feb-2020 10:10 AM

Broker Forecast - JP Morgan Cazenove issues a broker note on Dechra Pharmaceuticals PLC

JP Morgan Cazenove today reaffirms its overweight investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and raised its price target to 3300p (from 3200p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.
24-Feb-2020 07:57 AM

Dechra Pharm profit more than doubles, led European sales growth

Veterinary pharmaceuticals company Dechra Pharm said half-yearly profit more than doubled, led by 'strong' revenue in its European business, though it warned of supply challenges in North America. For the six months ended 31 December 2019, pre
21-Jan-2020 10:10 AM

Broker Forecast - Jefferies International issues a broker note on Dechra Pharmaceuticals PLC

Jefferies International today downgrades its investment rating on Dechra Pharmaceuticals PLC (LON:DPH) to hold (from buy) and cut its price target to 2930p (from 3090p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.shares
06-Jan-2020 11:10 AM

Broker Forecast - JP Morgan Cazenove issues a broker note on Dechra Pharmaceuticals PLC

JP Morgan Cazenove today reaffirms its overweight investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and cut its price target to 3200p (from 3500p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk.
02-Dec-2019 10:10 AM

Broker Forecast - HSBC issues a broker note on Dechra Pharmaceuticals PLC

HSBC today reaffirms its hold investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and raised its price target to 2950p (from 2915p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
30-Oct-2019 07:24 AM

Dechra appoints Paul Sandland as permanent CFO

Animal pharmaceuticals supplier Dechra Pharmaceuticals announced that it had appointed acting chief financial officer Paul Sandland to the position permanently. Between 2012 and 2013, Sandland was acting CFO prior to becoming the Dechra veterinary produc
18-Oct-2019 08:01 AM

Dechra Pharmaceuticals 'confident' about prospect as efforts to resolve supply issues continue

Dechra Pharmaceuticals said it would continue efforts to resolve its supply issues, but added that many of the issues had now been mitigated, leaving it 'confident' about its prospects for the current financial year. The company previously rep
04-Sep-2019 11:30 AM

Broker Forecast - JP Morgan Cazenove issues a broker note on Dechra Pharmaceuticals PLC

JP Morgan Cazenove today reaffirms its overweight investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and raised its price target to 3500p (from 3000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.
02-Sep-2019 07:48 AM

Dechra Pharmaceutical profit ticks lower despite 'exceptional' growth in US

Dechra Pharmaceutical reported a slight fall in profit even as the animal-drug developer outperformed in all its markets including in the US where it delivered 'exceptional' organic growth. For the financial year ended 30 June 2019, pretax
09-Jul-2019 07:44 AM

Dechra Pharmaceutical revenues lifted by 'good' market penetration, synergies from Le Vet acquisitio

Animal-drug developer Dechra Pharmaceutical said revenues increased by about 17% amid another year of 'strong growth' driven by 'good' market penetration and the realisation of significant synergies from Le Vet. For the financial yea
03-Apr-2019 07:44 AM

Dechra's Richard Cotton steps down as CFO for 'personal reasons'

Dechra said Richard Cotton, Chief Financial Officer, would leave the company immediately for 'personal reasons'. 'The Board has agreed that with immediate effect Richard will resign as Director and relinquish his current responsibilities
25-Mar-2019 12:50 PM

Broker Forecast - Jefferies International issues a broker note on Dechra Pharmaceuticals PLC

Jefferies International today reaffirms its buy investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and raised its price target to 2805p (from 2466p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk
25-Mar-2019 09:10 AM

Broker Forecast - JP Morgan Cazenove issues a broker note on Dechra Pharmaceuticals PLC

JP Morgan Cazenove today initiates coverage of Dechra Pharmaceuticals PLC (LON:DPH) with a overweight investment rating and price target of 3000p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
11-Mar-2019 11:40 AM

Broker Forecast - HSBC issues a broker note on Dechra Pharmaceuticals PLC

HSBC today reaffirms its buy investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and cut its price target to 2700p (from 2770p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
25-Feb-2019 04:25 PM

Dechra Pharmaceuticals underlying profit rises, led by North America

Dechra Pharmaceuticals, which develops drugs for animals, reported Monday first-half results that met its expectations, led by strong growth in its North American division. For the six months ended 31 December, underlying profit before taxation increased

a d v e r t i s e m e n t